[
  {
    "ts": "2025-07-04T17:18:13+00:00",
    "headline": "Vertex reports long-term results for Casgevy in sickle cell and thalassaemia",
    "summary": "Across 100 patients in three Phase III studies, Casgevy showed lasting benefits.",
    "url": "https://www.clinicaltrialsarena.com/news/vertex-reports-long-term-results-for-casgevy-in-sickle-cell-and-thalassaemia/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "677c58c3-e180-3ed3-a0b9-10f223980014",
      "content": {
        "id": "677c58c3-e180-3ed3-a0b9-10f223980014",
        "contentType": "STORY",
        "title": "Vertex reports long-term results for Casgevy in sickle cell and thalassaemia",
        "description": "",
        "summary": "Across 100 patients in three Phase III studies, Casgevy showed lasting benefits.",
        "pubDate": "2025-07-04T17:18:13Z",
        "displayTime": "2025-07-04T17:18:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/a96f6f39d4bb7711d344e4a407c4c09f",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Casgevy was approved by the US Food and Drug Administration in December 2023. Image credit: Butusova Elena / Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mo4nfjOrA9PizWcYYODmIw--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/a96f6f39d4bb7711d344e4a407c4c09f.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yIcQH8GA2903NEfsdNgqZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/a96f6f39d4bb7711d344e4a407c4c09f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/vertex-reports-long-term-results-for-casgevy-in-sickle-cell-and-thalassaemia/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-reports-long-term-results-171813784.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]